Pivotal bioVenture Partners
Pivotal bioVenture Partners is an investor named in the Raise Track Update as participating in Estuary Biotherapeutics' Series A.
- Type
- Venture capital firm
About
Pivotal bioVenture Partners participated in Estuary Biotherapeutics' $93 million Series A, announced on 2026-10-16. RA Capital Management led. 4BIO Capital's post writes Pivotal bioVentures. The company release and the Raise Track Update say Pivotal bioVenture Partners. This page uses Pivotal bioVenture Partners.
The Raise Track Update names Pivotal bioVenture Partners as an investor in: Estuary Biotherapeutics (2026-10-19).
This page is not indexed by search engines yet. It is promoted once it meets the quality gate for investor pages: a description from the firm's own website, a headquarters city and at least two two-sourced rounds on this site.
Funding rounds on RaiseTrack
| Company | Round | Date | Role |
|---|---|---|---|
| Estuary Biotherapeutics | Series A 2026 | 2026-10-16 | participant |
Sources
Last verified:
- https://estuarybio.com/news/estuary-series-a
Type: company announcement. Accessed 2026-10-19.
Estuary Biotherapeutics release, 16 October 2026. Names Pivotal bioVenture Partners as a participant in the Series A. - https://www.4biocapital.com/single-post/estuary-biotherapeutics-launches-with-103-million-to-advance-targeted-gene-therapies-for-kidney-dis
Type: official investor website. Accessed 2026-10-19.
4BIO Capital post, 16 October 2026. Writes Pivotal bioVentures. This page uses Pivotal bioVenture Partners, which is the name in the company release and the Raise Track Update. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-19/
Type: other verified public source. Accessed 2026-10-19.
Raise Track Update for 2026-10-19. Names this firm on Estuary Biotherapeutics' $93 million Series A.